The World Health Organization raised its national risk assessment for the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo to "very high" [1].
This escalation signals an urgent need for containment as the virus spreads rapidly across the region. The revised assessment reflects the potential for the outbreak to overwhelm local health systems if the transmission rate is not curtailed.
On May 22, 2026, the WHO International Health Regulations Emergency Committee met to discuss the epidemic [1]. The organization said the risk was "high" at the regional level and "low" at the global level [1].
Data regarding the scale of the outbreak varies across reports. The BBC reported more than 390 suspected cases and at least 100 deaths [2]. The Sydney Morning Herald cited nearly 400 suspected infections and more than 100 suspected deaths [6, 5]. Other reports from CBS News indicated more than 250 suspected cases and 80 suspected deaths [3, 4].
The WHO's decision to update the risk level follows the rapid spread of the disease within the Democratic Republic of the Congo [1, 2]. The organization said it is issuing temporary recommendations to protect public health and limit further transmission [1].
Health officials are monitoring the situation closely to prevent the virus from crossing further borders or escalating beyond the current regional risk level [1]. The focus remains on the Democratic Republic of the Congo, where the most acute impact is currently observed [2].
“The World Health Organization raised its national risk assessment for the Ebola Bundibugyo virus disease outbreak in the Democratic Republic of the Congo to "very high".”
The shift to a "very high" national risk level indicates that the Ebola Bundibugyo outbreak has reached a critical threshold in the Democratic Republic of the Congo. While the global risk remains low, the regional 'high' designation suggests a significant threat to neighboring countries. The discrepancy in case numbers—ranging from 250 to nearly 400—highlights the challenges of real-time surveillance in active epidemic zones.
